These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Drusen regression is associated with local changes in fundus autofluorescence in intermediate age-related macular degeneration. Toy BC; Krishnadev N; Indaram M; Cunningham D; Cukras CA; Chew EY; Wong WT Am J Ophthalmol; 2013 Sep; 156(3):532-542.e1. PubMed ID: 23830564 [TBL] [Abstract][Full Text] [Related]
5. Identification of Drusen Characteristics in Age-Related Macular Degeneration by Polarization-Sensitive Optical Coherence Tomography. Schlanitz FG; Sacu S; Baumann B; Bolz M; Platzer M; Pircher M; Hitzenberger CK; Schmidt-Erfurth U Am J Ophthalmol; 2015 Aug; 160(2):335-344.e1. PubMed ID: 25982973 [TBL] [Abstract][Full Text] [Related]
6. Retinal disease in the C3 glomerulopathies and the risk of impaired vision. Savige J; Amos L; Ierino F; Mack HG; Symons RC; Hughes P; Nicholls K; Colville D Ophthalmic Genet; 2016 Dec; 37(4):369-376. PubMed ID: 26915021 [TBL] [Abstract][Full Text] [Related]
7. Electrophysiology of type II mesangiocapillary glomerulonephritis with associated fundus abnormalities. O'Brien C; Duvall-Young J; Brown M; Short C; Bone M Br J Ophthalmol; 1993 Dec; 77(12):778-80. PubMed ID: 8110672 [TBL] [Abstract][Full Text] [Related]
8. Fluorescence characteristics of drusen during indocyanine-green angiography and their possible correlation with choroidal perfusion. Schwartz D Surv Ophthalmol; 1995; 39(5):425-6. PubMed ID: 7604367 [No Abstract] [Full Text] [Related]
9. [Choroidal neovascularisation in type II membranoproliferative glomerulonephritis, photodynamic therapy as a treatment option--a case report]. Hassenstein A; Richard G Klin Monbl Augenheilkd; 2003 Jul; 220(7):492-5. PubMed ID: 12886510 [TBL] [Abstract][Full Text] [Related]
10. EYES WITH SUBRETINAL DRUSENOID DEPOSITS AND NO DRUSEN: Progression of Macular Findings. Spaide RF; Yannuzzi L; Freund KB; Mullins R; Stone E Retina; 2019 Jan; 39(1):12-26. PubMed ID: 30312263 [TBL] [Abstract][Full Text] [Related]
12. Fundus changes in chronic membranoproliferative glomerulonephritis type II. Michielsen B; Leys A; Van Damme B; Missotten L Doc Ophthalmol; 1990-1991; 76(3):219-29. PubMed ID: 2103524 [TBL] [Abstract][Full Text] [Related]
13. Lifecycles of Individual Subretinal Drusenoid Deposits and Evolution of Outer Retinal Atrophy in Age-Related Macular Degeneration. Zhang Y; Wang X; Sadda SR; Clark ME; Witherspoon CD; Spaide RF; Owsley C; Curcio CA Ophthalmol Retina; 2020 Mar; 4(3):274-283. PubMed ID: 31924545 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of Peripheral Retinal Changes on Ultra-Widefield Fundus Autofluorescence Images of Patients with Age-Related Macular Degeneration. Küçükiba K; Erol N; Bilgin M Turk J Ophthalmol; 2020 Mar; 50(1):6-14. PubMed ID: 32166942 [TBL] [Abstract][Full Text] [Related]
15. Fundus autofluorescence in patients with age-related macular degeneration and high risk of visual loss. Lois N; Owens SL; Coco R; Hopkins J; Fitzke FW; Bird AC Am J Ophthalmol; 2002 Mar; 133(3):341-9. PubMed ID: 11860971 [TBL] [Abstract][Full Text] [Related]
16. Extensive drusen in type I membranoproliferative glomerulonephritis. Han DP; Sievers S Arch Ophthalmol; 2009 Apr; 127(4):577-9. PubMed ID: 19365045 [No Abstract] [Full Text] [Related]